Strategic Alliances

Antithrombotic Trials Leadership and Steering Group (ATLAS Group)

The ATLAS Group is an international panel of leading hematological and antithrombotic experts formed to design and lead the next generation of antithrombotic clinical trials. ATLAS functions to provide highly engaged expertise in leading protocol design, developing and implementing quality endpoint programs across the spectrum of thrombosis-related and bleeding-related outcome measures, providing independent interpretation of study findings, and leading presentations and publications of trial results. By utilizing the ATLAS Group, you benefit from independent academic experts through a single point of access, saving time and resources. The ATLAS Group was formed through a partnership between CPC Clinical Research and Worldwide Clinical Trials. For more information go to the following site: http://www.cpcmed.org/about-us/atlas-group.html .

Thomas Jefferson University, School of Population Health

Worldwide Clinical Trials and Thomas Jefferson University School of Population Health (JSPH) entered into a partnership in the spring of 2011 with the purpose of providing expanded clinical services to our clients.  The partnership broadens Worldwide Clinical Trials’ expertise and understanding of the payer and reimbursement needs that are ever more intrinsic to maximizing market access for our clients’ drugs.  
With JSPH academic leadership in all aspects of population health, specifically, health policy, and Worldwide Clinical Trials’ unparalleled expertise in drug development; the partnership will work together to design clinical trials that will meet or exceed the challenges set forth by healthcare reform.  This in turn, will provide our clients with the data and support they need to demonstrate value to payers and providers and ultimately, allow patients the benefit of access to vital medicines.
The Jefferson School of Population Health is an integral part of Thomas Jefferson University, the premier academic health center founded in Philadelphia, PA in 1824.  JSPH is a leading academic provider of education in the fields of health affordability, access to care and associated concerns around quality and safety.

Technology Partners

PHT Corporation

Worldwide Clinical Trials’ collaboration with PHT Corporation delivers impeccable trial data, facilitating the successful market access of your drug.
PHT is a leading, global provider of electronic patient reported outcome (ePRO) solutions and patient reported outcome measures (PROMS).  Their systems have transformed the quality of site-based questionnaire and survey data capture, among other measures, moving clinical research beyond dependency on interpreted patient responses.  When allied to Worldwide Clinical Trials’ medical and scientific expertise and global network of operations; our clients benefit from receiving data that enables faster, more cost efficient and scientifically focused studies.

Oracle Corporation

Worldwide Clinical Trials works closely with Oracle Corporation for the provision of the InForm Electronic Data Capture (EDC) application in a ‘Software as a Service’ model. The Oracle Health Sciences GTM platform and its supporting modules provide clinical sites and trial sponsors with all the tools required to efficiently conduct and manage EDC-based clinical trials.

With its intuitive user interface, multi-language capabilities, and associated software modules, the Oracle Health Sciences InForm GTM platform delivers a robust solution to meet the needs of today’s global EDC user.

We at Worldwide Clinical Trials manage the entire relationship for our sponsors, ensuring seamless study deployment and delivery through the entire project timeline.

Global Partners

To ensure optimum clinical operations for your study we work with select CRO partners in strategic locations around the world that include; CliniRx (India), Fountain Medical Devlopment Ltd (China) and Linical Co., Ltd (Japan).